Free Trial

BNP Paribas Financial Markets Reduces Holdings in Keurig Dr Pepper Inc. (NASDAQ:KDP)

Keurig Dr Pepper logo with Consumer Staples background

BNP Paribas Financial Markets cut its stake in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 4.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,562,197 shares of the company's stock after selling 118,686 shares during the period. BNP Paribas Financial Markets owned approximately 0.19% of Keurig Dr Pepper worth $96,031,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of KDP. Avestar Capital LLC boosted its holdings in shares of Keurig Dr Pepper by 10.2% during the third quarter. Avestar Capital LLC now owns 19,648 shares of the company's stock valued at $736,000 after acquiring an additional 1,825 shares during the period. Brooklyn Investment Group acquired a new stake in Keurig Dr Pepper in the 3rd quarter valued at about $61,000. FMR LLC raised its holdings in Keurig Dr Pepper by 9.8% during the 3rd quarter. FMR LLC now owns 102,183,144 shares of the company's stock worth $3,829,824,000 after buying an additional 9,105,164 shares during the period. Qsemble Capital Management LP raised its holdings in Keurig Dr Pepper by 428.0% during the 3rd quarter. Qsemble Capital Management LP now owns 59,618 shares of the company's stock worth $2,234,000 after buying an additional 48,326 shares during the period. Finally, Bank of Montreal Can raised its holdings in Keurig Dr Pepper by 0.7% during the 3rd quarter. Bank of Montreal Can now owns 1,264,222 shares of the company's stock worth $47,307,000 after buying an additional 8,206 shares during the period. 85.23% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

KDP has been the topic of a number of research reports. Wells Fargo & Company dropped their price objective on Keurig Dr Pepper from $43.00 to $42.00 and set an "overweight" rating on the stock in a report on Friday, October 25th. Evercore ISI upgraded Keurig Dr Pepper to a "hold" rating in a research note on Thursday, September 5th. Deutsche Bank Aktiengesellschaft raised their target price on Keurig Dr Pepper from $36.00 to $37.00 and gave the company a "hold" rating in a research note on Monday, September 23rd. Royal Bank of Canada raised their target price on Keurig Dr Pepper from $41.00 to $42.00 and gave the stock an "outperform" rating in a report on Friday, October 25th. Finally, Citigroup reduced their target price on Keurig Dr Pepper from $43.00 to $40.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $38.36.

Read Our Latest Research Report on KDP

Insider Buying and Selling

In other Keurig Dr Pepper news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of Keurig Dr Pepper stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $32.65, for a total value of $2,252,850,000.00. Following the transaction, the insider now directly owns 214,443,879 shares of the company's stock, valued at approximately $7,001,592,649.35. The trade was a 24.34 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.00% of the stock is currently owned by company insiders.

Keurig Dr Pepper Stock Down 0.6 %

Shares of Keurig Dr Pepper stock traded down $0.20 during midday trading on Wednesday, hitting $32.45. The company had a trading volume of 1,869,384 shares, compared to its average volume of 9,256,126. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.36 and a current ratio of 0.53. The stock has a market capitalization of $44.02 billion, a P/E ratio of 19.79, a P/E/G ratio of 2.54 and a beta of 0.63. The company has a 50 day moving average of $35.01 and a 200 day moving average of $34.70. Keurig Dr Pepper Inc. has a 52-week low of $28.61 and a 52-week high of $38.28.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The company reported $0.51 earnings per share for the quarter, meeting the consensus estimate of $0.51. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The firm had revenue of $3.89 billion for the quarter, compared to analysts' expectations of $3.92 billion. During the same period in the prior year, the firm earned $0.48 EPS. The company's revenue was up 2.3% compared to the same quarter last year. On average, equities analysts predict that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current fiscal year.

Keurig Dr Pepper Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were given a dividend of $0.23 per share. This is a positive change from Keurig Dr Pepper's previous quarterly dividend of $0.22. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.84%. Keurig Dr Pepper's dividend payout ratio (DPR) is presently 55.76%.

Keurig Dr Pepper Company Profile

(Free Report)

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

Featured Articles

Institutional Ownership by Quarter for Keurig Dr Pepper (NASDAQ:KDP)

Should you invest $1,000 in Keurig Dr Pepper right now?

Before you consider Keurig Dr Pepper, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.

While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines